Knorr DA - Search Results

1

Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity.

Woll PS, Grzywacz B, Tian X, Marcus RK, Knorr DA, Verneris MR, Kaufman DS. Woll PS, et al. Among authors: knorr da. Blood. 2009 Jun 11;113(24):6094-101. doi: 10.1182/blood-2008-06-165225. Epub 2009 Apr 13. Blood. 2009. PMID: 19365083 Free PMC article.

2

Development, expansion, and in vivo monitoring of human NK cells from human embryonic stem cells (hESCs) and and induced pluripotent stem cells (iPSCs).

Bock AM, Knorr D, Kaufman DS. Bock AM, et al. J Vis Exp. 2013 Apr 23;(74):e50337. doi: 10.3791/50337. J Vis Exp. 2013. PMID: 23644738 Free PMC article.

3

Pluripotent stem cell-derived natural killer cells for cancer therapy.

Knorr DA, Kaufman DS. Knorr DA, et al. Transl Res. 2010 Sep;156(3):147-54. doi: 10.1016/j.trsl.2010.07.008. Epub 2010 Aug 1. Transl Res. 2010. PMID: 20801411 Free PMC article. Review.

4

Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanisms.

Ni Z, Knorr DA, Clouser CL, Hexum MK, Southern P, Mansky LM, Park IH, Kaufman DS. Ni Z, et al. Among authors: knorr da. J Virol. 2011 Jan;85(1):43-50. doi: 10.1128/JVI.01774-10. Epub 2010 Oct 20. J Virol. 2011. PMID: 20962093 Free PMC article.

5

Engineered human embryonic stem cell-derived lymphocytes to study in vivo trafficking and immunotherapy.

Knorr DA, Bock A, Brentjens RJ, Kaufman DS. Knorr DA, et al. Stem Cells Dev. 2013 Jul 1;22(13):1861-9. doi: 10.1089/scd.2012.0608. Epub 2013 Mar 28. Stem Cells Dev. 2013. PMID: 23421330 Free PMC article.

6

Clinical-scale derivation of natural killer cells from human pluripotent stem cells for cancer therapy.

Knorr DA, Ni Z, Hermanson D, Hexum MK, Bendzick L, Cooper LJ, Lee DA, Kaufman DS. Knorr DA, et al. Stem Cells Transl Med. 2013 Apr;2(4):274-83. doi: 10.5966/sctm.2012-0084. Epub 2013 Mar 20. Stem Cells Transl Med. 2013. PMID: 23515118 Free PMC article.

7

Hematopoietic and nature killer cell development from human pluripotent stem cells.

Ni Z, Knorr DA, Kaufman DS. Ni Z, et al. Among authors: knorr da. Methods Mol Biol. 2013;1029:33-41. doi: 10.1007/978-1-62703-478-4_3. Methods Mol Biol. 2013. PMID: 23756940

8

Expression of chimeric receptor CD4ζ by natural killer cells derived from human pluripotent stem cells improves in vitro activity but does not enhance suppression of HIV infection in vivo.

Ni Z, Knorr DA, Bendzick L, Allred J, Kaufman DS. Ni Z, et al. Among authors: knorr da. Stem Cells. 2014 Apr;32(4):1021-31. doi: 10.1002/stem.1611. Stem Cells. 2014. PMID: 24307574 Free PMC article.

9

Clinical utility of natural killer cells in cancer therapy and transplantation.

Knorr DA, Bachanova V, Verneris MR, Miller JS. Knorr DA, et al. Semin Immunol. 2014 Apr;26(2):161-72. doi: 10.1016/j.smim.2014.02.002. Epub 2014 Mar 5. Semin Immunol. 2014. PMID: 24618042 Free PMC article. Review.

10

RUNX1a enhances hematopoietic lineage commitment from human embryonic stem cells and inducible pluripotent stem cells.

Ran D, Shia WJ, Lo MC, Fan JB, Knorr DA, Ferrell PI, Ye Z, Yan M, Cheng L, Kaufman DS, Zhang DE. Ran D, et al. Among authors: knorr da. Blood. 2013 Apr 11;121(15):2882-90. doi: 10.1182/blood-2012-08-451641. Epub 2013 Jan 31. Blood. 2013. PMID: 23372166 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters